Usability of a Home-Based Test for the Measurement of Fecal Calprotectin in Asymptomatic IBD Patients Digestive and Liver Disease

IBDoc® Citation:

Bello C, Roseth A, Guardiola J, Reenaers C, Ruiz-Cerulla A, Kemseke C Van, Arajol C, Reinhard C, Seidel L, Louis E.Usability of a home-based test for the measurement of fecal calprotectin in asymptomatic IBD patients. Digestive and Liver Disease. 2017 May 19. pii: S1590-8658(17)30886-1. http://dx.doi.org/10.1016/j.dld.2017.05.009 PMID: 28587751

Highlights from this Publication

“ …Globally, the correlation between the FC measured by the home-based tool and the central ELISA was good. Particularly when FC values were categorized in normal, borderline or high, only a minority were misclassified…”
“…We found that the usability, as measured by two different usability scores, can be considered as excellent…”

“…The sensitivity, specificity, negative predictive value and positive predictive value of the homebased test to predict a fecal calprotectin > 300 µg/g by ELISA were, 89.8%, 95.5%, 91.4% and 94.6%…”

Health Canada License: 98903
US: Not available for Sale in the US.

Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedInEmail this to someone